Sterling Capital Management’s Lexicon Pharmaceuticals LXRX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-1,280
| Closed | -$590 | – | 3336 |
|
|
2025
Q1 | $590 | Sell |
1,280
-1,197
| -48% | -$552 | ﹤0.01% | 2935 |
|
|
2024
Q4 | $1.83K | Buy |
2,477
+2,205
| +811% | +$1.63K | ﹤0.01% | 2806 |
|
|
2024
Q3 | $427 | Buy |
+272
| New | +$427 | ﹤0.01% | 2933 |
|
|
2017
Q1 | – | Sell |
-14,112
| Closed | -$195K | – | 981 |
|
|
2016
Q4 | $195K | Hold |
14,112
| – | – | ﹤0.01% | 911 |
|
|
2016
Q3 | $255K | Buy |
+14,112
| New | +$255K | ﹤0.01% | 830 |
|